H. Lee Herron, DVM
Vice President, Venture Development
Dr. Lee Herron directs the GRA Ventures Program which offers a wide range of services to launch high-growth companies around university discoveries. In this role, Herron oversees the selection of projects eligible for GRA support via commercialization grants, loans, and expert consulting services. Herron also leads the development of potential investment prospects for consideration by the GRA Venture Fund LLC. Under Herron’s leadership, the GRA Ventures Program has launched 150 new companies and created nearly 1,500 jobs. GRA’s portfolio of companies has attracted more than $1 billion in equity investment to date.
Prior to joining the Georgia Research Alliance, Dr. Herron was General Manager, Biosciences, for the Advanced Technology Development Center. In this capacity, Dr. Herron advised start-up and early stage companies regarding the growth and development of their organizations. Through the GRA Ventures program at Georgia Tech, he worked with faculty at Georgia Tech to evaluate commercial opportunities and to pursue new venture formation or licensing opportunities. He also served as CEO EmTech Bio, a collaborative program of Georgia Tech and Emory.Before joining ATDC, Dr. Herron worked with BRAHMS AG, a German manufacturer of in-vitro diagnostic products, to establish its North American operations. Earlier, he was the founder, President and CEO of SeaLite Sciences, Inc., a company focused on the development and commercialization of diagnostic products and molecular biology reagents. Dr. Herron was also a founding team member of three other bioscience companies, Biopool International, Inc., CytRx Corporation and Theragenics Corporation. He earned his Doctor of Veterinary Medicine degree from the University of Georgia.